Identification and Treatment of High-Risk Neurogenic Bladder
Can the Global Urological Community Eliminate Preventable Kidney Disease?
Renal failure is the risk inherent to the neurogenic bladder. Historically, in pre-urodynamic era renal dysfunction occurred in half the patients with spina bifida and in almost all the patients with spinal cord injuries leading to death in both groups. Intense research in the field has significantly contained morbidity and improved the quality of life of these patients. The introduction of clean intermittent catheterization (CIC) in the 70s improved mortality from sepsis but the risk of renal failure persisted. Contemporaneous pharmacologic interventions help to sustain bladder pressures within the safe range. Over the past few decades, long term management of neuropathic bladders has emerged as a speciality within the speciality of Urology. Personalized treatment of the high-risk patients with neuropathic bladder during the different stages of progression needs focused attention of the urologist. We have invited Drs. Sinha, Enrico and Rizwan, internationally recognized authorities on the subject to enlighten the participants with the fineries of the overall care beyond CIC and treatment of urinary tract infection. This Master Class would be immensely useful for practising urologists and postgraduates alike who are desirous of understanding the subject at the conceptual level. Following the formal presentations listed below, several case studies are considered by the panel, starting at 54:38.
Presented by the Vattikuti Foundation in collaboration with the International Continence Society.
Dr Sanjay Sinha, India (Presentation 25:30 – 42:06)
Dr Enrico Finazzi Agrò, Italy (Presentation 11:15 – 25:30)
Dr Rizwan Hamid, UK (Presentation 25:30 – 42:06)
Dr Mahendra Bhandari, US (Welcome, panel discussion)